Perinatal outcomes in pregnant women with COVID-19 at different gestational ages and disease severities

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: Investigation of the impact of gestational age and the severity of Coronavirus Disease 2019 (COVID-19) on pregnancy outcomes is of particular importance in the context of the continuing relevance of this issue, as well as for the development of preventive strategies and therapeutic approaches aimed at reducing adverse maternal and fetal outcomes.

AIM: To evaluate perinatal outcomes in pregnant women who developed COVID-19 at different gestational ages and with varying degrees of disease severity.

METHODS: Perinatal outcomes were analyzed in pregnant women from three clinical groups: group 1, patients who developed COVID-19 during the first trimester (n = 119); group 2, patients infected during the second trimester (n = 121); group 3, patients infected during the third trimester of pregnancy (n = 120). Each clinical group was further divided into three subgroups according to the severity of COVID-19 (mild, moderate, and severe). Statistical analysis of the clinical data was performed using StatSoft software (Russia). Differences were considered statistically significant at p < 0.05.

RESULTS: The analysis showed that severe SARS-CoV-2 infection occurring in the first trimester of gestation contributes to pregnancy termination in more than 50% of clinical cases. At the same time, patients who had mild COVID-19 in early gestation significantly more frequently delivered infants with normal birth weight and favorable early neonatal adaptation compared with those born to mothers with moderate or severe COVID-19. SARS-CoV-2 infection during the second trimester identified pregnant women as a high-risk group for adverse perinatal outcomes, including fetal growth restriction, and increased the likelihood of complicated early neonatal adaptation. In pregnant women who developed COVID-19 during the third trimester, a high risk of acute fetal hypoxia and abdominal delivery was observed, not only for obstetric indications but also due to a more severe COVID-19 course. The higher rate of preterm birth among infants born to mothers with severe COVID-19 during the second and third trimesters was associated with earlier medically indicated delivery and with pathological maternal changes caused by infection-related hypoxia.

CONCLUSION: The study demonstrated that the distribution and frequency of perinatal complications depend on both the gestational age and the severity of COVID-19.

About the authors

Sergey P. Sinchikhin

Astrakhan State Medical University; Saratov State Medical University n.a. V.I. Razumovsky

Author for correspondence.
Email: doc_sinchihin@mail.ru
ORCID iD: 0000-0001-6184-1741
SPIN-code: 8225-2239

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Astrakhan; Saratov

Maria A. Kuzmina

Astrakhan State Medical University

Email: kuz188@yandex.ru
ORCID iD: 0009-0008-4326-5101
SPIN-code: 5178-1641

Cand. Sci. (Medicine), Assistant Professor

Russian Federation, Astrakhan

Onsi Nasri

Astrakhan State Medical University

Email: Nasri.onsi@yandex.ru
ORCID iD: 0000-0002-0030-2389
Russian Federation, Astrakhan

Olga G. Chernikina

Astrakhan State Medical University

Email: chernikina0@rambler.ru
ORCID iD: 0000-0001-8778-4802
SPIN-code: 4634-6026

Cand. Sci. (Medicine), Assistant Professor

Russian Federation, Astrakhan

Ekaterina S. Alexandrova

Astrakhan State Medical University

Email: es.sinchikhina@mail.ru
ORCID iD: 0000-0002-3949-4349
SPIN-code: 5119-1348
Russian Federation, Astrakhan

Gevork O. Magakyan

Russian National Research Medical University n.a. N.I. Pirogov

Email: magakyan_02@mail.ru
ORCID iD: 0009-0004-3428-7895
Russian Federation, Moscow

References

  1. Czeresnia RM, Trad ATA, Britto ISW, et al. SARS-CoV-2 and Pregnancy: A Review of the Facts. Rev Bras Ginecol Obstet. 2020;42(9):562–568. doi: 10.1055/s-0040-1715137
  2. Nasri O, Kuzmina MA, Sinchikhin SP, et al. Clinical and anamnestic data of pregnant women with different courses of novel coronavirus infection. Astrakhan Medical Journal. 2023;18(1):59–65. doi: 10.29039/1992-6499-2023-1-59-65 EDN: QRHKAV
  3. Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature. J Microbiol Immunol Infect. 2019;52(3):501–503. doi: 10.1016/j.jmii.2018.04.005
  4. Sunder A, Varghese B, Darwish B, et al. Impacts and effects of COVID-19 infection in pregnancy. Saudi Med J. 2022;43(1):67–74. doi: 10.15537/smj.2022.43.1.20210694
  5. Yerkenova S, Lokshin V, Saduakassova Sh, et al. Preconception care to improve pregnancy outcomes in COVID-19 survival women: a systematic review. Research Journal of Pharmacy and Technology. 2023;16(11):5485–1. doi: 10.52711/0974-360X.2023.00887
  6. Ikhtiyarova, GA, Dustova NK, Khasanova MA, et al. Pathomorphological changes of the placenta in pregnant women infected with coronavirus COVID-19. International Journal of Pharmaceutical Research. 2021;13(1):1935–1942. doi: 10.31838/ijpr/2021.13.01.283
  7. Belokrinitskaya IE, Filippov OS, Frolova NI, Kolmakova KA. Critical obstetric conditions in the Far East federal district of Russia before and during the COVID-19 pandemic. Doctor.ru. 2022;21(1):7–12. doi: 10.31550/1727-2378-2022-21-1-7-12 EDN: KIPEAV
  8. Khvorostukhina NF, Sheveleva DI, Novichkov DA, et al. Obstetric and perinatal outcomes after new coronavirus infection in the first and second trimesters of pregnancy. Medical Council. 2023;17(23):259–267 doi: 10.21518/ms2023-472 EDN: GMSJRS
  9. Jafari M, Pormohammad A, Sheikh Neshin SA, et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol. 2021;31(5):1–16. doi: 10.1002/rmv.2208
  10. Delahoy MJ, Whitaker M, O’Halloran A, et al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — COVID-NET, 13 states, March 1 — August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1347–1354. doi: 10.15585/mmwr.mm6938e1
  11. Grigoryeva EV, Tyapkina DA, Boroday AA, et al. Features of the course of COVID-19 in pregnant women. The Clinician. 2023;17(2):28–38. doi: 10.17650/1818-8338-2023-17-2-K683 EDN: IETXIS
  12. Dzhabbarova LA. Coronavirus infection as a risk factor for premature birth. In: Collection of abstracts of the LXXXV scientific and practical conference with international participation “Topical issues of experimental and clinical medicine-2024”. St. Petersburg; 2024. P. 7–8. EDN: PHPLJJ
  13. Davlyatova MF, Karimova DG. Assessment of predictors of the development of heavy forms of Sars-Cov-2 during pregnancy. Health Сare of Tajikistan. 2021;(4):33–40. doi: 10.52888/0514-2515-2021-351-4-33-40 EDN: JZVZRT
  14. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy. living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320
  15. Kosolapova YuA, Boris DA, Poludenko ND. Impact of the novel coronavirus infection (COVID-19) experienced by pregnant women on the health of newborns. Akusherstvo i Ginekologiya. 2022;(11): 90–98. doi: 10.18565/aig.2022.11.90-98 EDN: OLJUCY
  16. Voropaeva EE, Khaidukova YuV, Kazachkova EA, et al. Perinatal outcomes and morphological examination of placentas in pregnant women with critical lung lesions in new COVID-19 coronavirus infection. Ural Medical Journal. 2023;22(2):109–121. doi: 10.52420/2071-5943-2023-22-2-109-121 EDN: CXRCMN
  17. Panova LD, Khismatullina ZR, Gurova ZG, et al. COVID-19 and infants: clinic, diagnosis and treatment tactics (literature review). Russian Journal of Woman and Child Health. 2025;8(2):156–165. doi: 10.32364/2618-8430-2025-8-2-11 EDN: JWVNXN
  18. Kuneshko NF, Gavrikova DI, Golomazova VA, Kim VV. Analysis of the condition of newborn children of patients survived coronavirus infection. Medical & Pharmaceutical Journal Pulse. 2022;24(6):11–16. doi: 10.26787/nydha-2686-6838-2022-24-6-11-16 EDN: IGYZIU
  19. Ishchenko LS, Voropaeva EE, Kazachkova EA, et al. Features of COVID-19 of varying severity IN pregnant women. Doctor.ru. 2025;24(5):28–41. doi: 10.31550/1727-2378-2025-24-5-28-41 EDN: DARAHW
  20. Gold S, Clarfield L, Johnstone J, et al. Adapting obstetric and neonatal services during the COVID-19 pandemic: a scoping review. BMC Pregnancy Childbirth. 2022;22(1):119. doi: 10.1186/s12884-022-04409-4
  21. Mikhailova EV, Burova OS, Denisyuk NE, Romanovskaya AV. Novel coronavirus infection in newborns. Russian Bulletin of Perinatology and Pediatrics. 2022;67(4):242. (In Russ.) EDN: LVDDDG

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).